Xilis

Xilis is a biotechnology company developing a precision oncology platform that guides oncologists' treatment decisions to improve cancer care outcomes for patients and supports pharmaceutical companies in drug discovery and development. Xilis' proprietary MicroOrganoSphere™ (MOS) technology consists of miniature patient tumors, capturing the complete microenvironment and heterogeneity while providing an automated and scalable solution. Xilis is utilizing MOS and AI-driven algorithms to develop the Xilis Response Score™ for clinics, enabling oncologists to make informed and timely treatment decisions.